Showing 1 - 15 results of 15 for search 'E. S. Kropacheva', query time: 0.08s Refine Results
  1. 1
    SAFETY OF LONGTERM THERAPY WITH WARFARIN: POSSIBILITY OF TREATMENT RENEWING AFTER HEMORRHAGIC COMPLICATIONS

    SAFETY OF LONGTERM THERAPY WITH WARFARIN: POSSIBILITY OF TREATMENT RENEWING AFTER HEMORRHAGIC COMPLICATIONS by E. S. Kropacheva

    Published 2016
    Connect to this object online.
    Book
    Save to List
    Saved in:
  2. 2
    SAFETY ISSUES IN THE TREATMENT OF PATIENTS TAKING DABIGATRAN

    SAFETY ISSUES IN THE TREATMENT OF PATIENTS TAKING DABIGATRAN by E. S. Kropacheva

    Published 2016
    Connect to this object online.
    Book
    Save to List
    Saved in:
  3. 3
    SAFETY OF THERAPY AND PATRONAGE SYSTEM IN PATIENTS WHO RECEIVE WARFARIN

    SAFETY OF THERAPY AND PATRONAGE SYSTEM IN PATIENTS WHO RECEIVE WARFARIN by E. S. Kropacheva

    Published 2015
    Connect to this object online.
    Book
    Save to List
    Saved in:
  4. 4
    Intracardiac thrombosis: frequency, risk factors and place of oral anticoagulants in treatment

    Intracardiac thrombosis: frequency, risk factors and place of oral anticoagulants in treatment by E. S. Kropacheva

    Published 2020
    Connect to this object online.
    Book
    Save to List
    Saved in:
  5. 5
    SAFETY OF LONGTERM THERAPY WITH WARFARIN: POSSIBILITY OF TREATMENT RENEWING AFTER HEMORRHAGIC COMPLICATIONS

    SAFETY OF LONGTERM THERAPY WITH WARFARIN: POSSIBILITY OF TREATMENT RENEWING AFTER HEMORRHAGIC COMPLICATIONS by E. S. Kropacheva

    Published 2016
    Connect to this object online.
    Book
    Save to List
    Saved in:
  6. 6
    SELECTING AN OPTIMAL LONG-TERM ANTICOAGULANT THERAPY FOR A PATIENT WITH ATRIAL FIBRILLATION AND RECURRENT MINOR HEMORRHAGE. CLINICAL FOLLOW-UP

    SELECTING AN OPTIMAL LONG-TERM ANTICOAGULANT THERAPY FOR A PATIENT WITH ATRIAL FIBRILLATION AND RECURRENT MINOR HEMORRHAGE. CLINICAL FOLLOW-UP by E. S. Kropacheva, E. P. Panchenko

    Published 2017
    Connect to this object online.
    Book
    Save to List
    Saved in:
  7. 7
    The place of dabigatran in the treatment of patients with atrial fibrillation in the light of modern recommendations

    The place of dabigatran in the treatment of patients with atrial fibrillation in the light of modern recommendations by E. S. Kropacheva, E. P. Panchenko

    Published 2023
    Connect to this object online.
    Book
    Save to List
    Saved in:
  8. 8
    Aspects of anticoagulant therapy in patients with atrial fibrillation in the light of updated guidelines of the European society of cardiology 2020: the position of dabigatran

    Aspects of anticoagulant therapy in patients with atrial fibrillation in the light of updated guidelines of the European society of cardiology 2020: the position of dabigatran by E. S. Kropacheva, E. P. Panchenko

    Published 2020
    Connect to this object online.
    Book
    Save to List
    Saved in:
  9. 9
    ASPECTS OF MULTICOMPONENT THERAPY AND PERIOPERATIVE TACTICS IN A PATIENT WITH ATRIAL FIBRILLATION RECEIVING RIVAROXABAN THERAPY. CLINICAL OBSERVATION

    ASPECTS OF MULTICOMPONENT THERAPY AND PERIOPERATIVE TACTICS IN A PATIENT WITH ATRIAL FIBRILLATION RECEIVING RIVAROXABAN THERAPY. CLINICAL OBSERVATION by O. A. Zemlyanskaya, E. S. Kropacheva

    Published 2019
    Connect to this object online.
    Book
    Save to List
    Saved in:
  10. 10
    Rivaroxaban in patients with atrial fibrillation: from research to real practice (based on REGistry of Long-term AnTithrombotic TherApy-2 (REGATA))

    Rivaroxaban in patients with atrial fibrillation: from research to real practice (based on REGistry of Long-term AnTithrombotic TherApy-2 (REGATA)) by E. S. Kropacheva, E. N. Krivosheeva, E. P. Panchenko

    Published 2021
    Connect to this object online.
    Book
    Save to List
    Saved in:
  11. 11
    CLINICAL FACTORS AND ANTICOAGULATION LEVEL THAT DETERMINE THE SUDDEN LOSS OF KIDNEY FUNCTION IN PATIENTS LONG-TAKING WARFARIN (A 5-YEAR PROSPECTIVE, OBSERVATIONAL STUDY)

    CLINICAL FACTORS AND ANTICOAGULATION LEVEL THAT DETERMINE THE SUDDEN LOSS OF KIDNEY FUNCTION IN PATIENTS LONG-TAKING WARFARIN (A 5-YEAR PROSPECTIVE, OBSERVATIONAL STUDY) by E. S. Kropacheva, O. A. Zemlyanskaya, A. В. Dobrovolsky, Е. P. Panchenko

    Published 2018
    Connect to this object online.
    Book
    Save to List
    Saved in:
  12. 12
    THE EFFICACY OF LONG-TERM WARFARIN THERAPY: THE IMPACT ON THE INCIDENCE OF ISCHEMIC CEREBROVASCULAR DISORDERS AND CLINICAL PREDICTORS OF DEVELOPING SUCH DISORDERS. (Results of a prospective 10-year follow-up study)

    THE EFFICACY OF LONG-TERM WARFARIN THERAPY: THE IMPACT ON THE INCIDENCE OF ISCHEMIC CEREBROVASCULAR DISORDERS AND CLINICAL PREDICTORS OF DEVELOPING SUCH DISORDERS. (Results of a pr... by E. S. KROPACHEVA, O. A. ZEMLYANSKAYA, A. B. DOBROVOLSKY, E. P. PANCHENKO

    Published 2017
    Connect to this object online.
    Book
    Save to List
    Saved in:
  13. 13
    Need to determine the residual concentrations of direct oral anticoagulants in patients with atrial fibrillation undergoing transcatheter implantation of the aortic valve

    Need to determine the residual concentrations of direct oral anticoagulants in patients with atrial fibrillation undergoing transcatheter implantation of the aortic valve by A. I. Staroverova, E. S. Kropacheva, A. B. Dobrovolsky, E. V. Titaeva, E. P. Panchenko

    Published 2023
    Connect to this object online.
    Book
    Save to List
    Saved in:
  14. 14
    SAFETY OF LONG-TERM THERAPY WITH WARFARIN: HEMORRHAGE FREQUENCY AND CLINICAL PREDICTORS (results of a prospective 15-year follow-up)

    SAFETY OF LONG-TERM THERAPY WITH WARFARIN: HEMORRHAGE FREQUENCY AND CLINICAL PREDICTORS (results of a prospective 15-year follow-up) by E. S. Kropacheva, O. A. Zemlyanskaya, E. P. Panchenko, A. B. Dobrovolsky, E. N. Krivosheeva

    Published 2017
    Connect to this object online.
    Book
    Save to List
    Saved in:
  15. 15
    Modern possibilities and prospects in evaluating the anticoagulant effect of direct oral anticoagulants

    Modern possibilities and prospects in evaluating the anticoagulant effect of direct oral anticoagulants by A. I. Mironova, E. S. Kropacheva, A. B. Dobrovolsky, E. V. Titaeva, E. P. Panchenko

    Published 2022
    Connect to this object online.
    Book
    Save to List
    Saved in:

Search Tools: